Apyx Medical (APYX) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Apyx Medical (APYX) closed at $6.31, marking a -0.63% move from the previous day. This change lagged the S&P 500's daily gain of 0.67%. At the same time, the Dow added 0.82%, and the tech-heavy Nasdaq gained 0.78%.
Prior to today's trading, shares of the medical device maker had lost 9.54% over the past month. This has lagged the Medical sector's gain of 0.38% and the S&P 500's gain of 1.25% in that time.
Wall Street will be looking for positivity from APYX as it approaches its next earnings report date. On that day, APYX is projected to report earnings of -$0.19 per share, which would represent a year-over-year decline of 533.33%. Meanwhile, our latest consensus estimate is calling for revenue of $5.83 million, down 41.23% from the prior-year quarter.
APYX's full-year Zacks Consensus Estimates are calling for earnings of -$0.71 per share and revenue of $25.51 million. These results would represent year-over-year changes of -144.83% and -17.68%, respectively.
Investors should also note any recent changes to analyst estimates for APYX. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 71.95% lower. APYX is holding a Zacks Rank of #3 (Hold) right now.
The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 89, which puts it in the top 35% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Click to get this free report
Bovie Medical Corporation (APYX): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.